AIZ
73
2
BRK.B
38
4
INTC
56
4
VMC
59
2
V
66
4
PGR
49
2
PX
80
2
CNX
53
9
CF
53
2
TRIP
70
10
IBM
71
3
ABT
50
2
NOV
50
-2
ROP
59
5
MMM
64
-4
TRV
36
3
TGT
50
-3
MCK
64
4
RIG
23
-5
VNO
55
-4
AIZ
73
2
BRK.B
38
4
INTC
56
4
VMC
59
2
V
66
4
PGR
49
2
PX
80
2
CNX
53
9
CF
53
2
TRIP
70
10
IBM
71
3
ABT
50
2
NOV
50
-2
ROP
59
5
MMM
64
-4
TRV
36
3
TGT
50
-3
MCK
64
4
RIG
23
-5
VNO
55
-4
Financhill
Back

Financial Select Sector SPDR Fund Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
74

XLF
Financial Select Sector SPDR Fund

Last Price:
$53.17
Seasonality Move:
0.59%
Sell
31

APLS
Apellis Pharmaceuticals

Last Price:
$18.24
Seasonality Move:
-16.64%
Buy
74
Financial Select Sector SPDR Fund (XLF) is a Buy

Is Financial Select Sector SPDR Fund a Buy, Sell or Hold?

  • The current Financial Select Sector SPDR Fund [XLF] share price is $53.19. The Score for XLF is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
  • XLF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $18.26. The Score for APLS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XLF Stock Price Chart

What is Financial Select Sector SPDR Fund's stock price today?

  • The Financial Select Sector SPDR Fund share price today is $53.19
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XLF is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $18.26
    The current trend is relatively stagnant and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

XLF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.62 Buy
Relative Strength Index (14 RSI): 71.97 Buy
Chaikin Money Flow: 18696489 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.41 - 52.01) Buy
Bollinger Bands (100): (47.98 - 51.8) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 50.59 Buy
Chaikin Money Flow: 891120 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.6 - 19.1) Sell
Bollinger Bands (100): (17.22 - 24.96) Sell

XLF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52.2 Buy
20-day SMA: 51.28 Buy
50-day SMA: 50.54 Buy
200-day SMA: 49.07 Buy
8-day EMA: 52.24 Buy
20-day EMA: 51.53 Buy
50-day EMA: 50.69 Buy
200-day EMA: 48.46 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.01 Buy
20-day SMA: 18.4 Sell
50-day SMA: 18.14 Buy
200-day SMA: 25.87 Sell
8-day EMA: 17.97 Buy
20-day EMA: 18.12 Buy
50-day EMA: 18.85 Sell
200-day EMA: 26.2 Sell

Financial Select Sector SPDR Fund Earnings Growth & XLF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.24 per share, and an increase next year of $0.74 per share.

Financial Select Sector SPDR Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):